139 related articles for article (PubMed ID: 7571387)
1. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs.
Petersen SW; Rosin E
Vet Surg; 1995; 24(4):347-51. PubMed ID: 7571387
[TBL] [Abstract][Full Text] [Related]
2. Relationships between in vitro susceptibility and efficacy in experimental mouse infection-protection assay of cefazolin and cephalothin using Escherichia coli strains.
Uri JV; Actor P; Phillips L; Guarini JR; Weisbach JA
Chemotherapy; 1976; 22(5):313-8. PubMed ID: 780071
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
Hsieh WC; Ho SW
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
[TBL] [Abstract][Full Text] [Related]
4. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
Siebert WT; Moreland N; Williams TW
J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
[TBL] [Abstract][Full Text] [Related]
5. Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin.
Yeh LL; Chi CL
Int J Antimicrob Agents; 2001 Jun; 17(6):521-4. PubMed ID: 11397625
[TBL] [Abstract][Full Text] [Related]
6. A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
Actor P; Uri JV; Guarini JR; Zajac I; Phillips L; Sachs CS; DeMarinis RM; Hoover JR; Weisbach JA
J Antibiot (Tokyo); 1975 Jun; 28(6):471-6. PubMed ID: 238925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
Greenberg RN; Bollinger M
Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
[TBL] [Abstract][Full Text] [Related]
8. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
Knothe H
Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
[TBL] [Abstract][Full Text] [Related]
9. Activity of cephalosporins against coagulase-negative staphylococci.
Chin NX; Neu NM; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
[TBL] [Abstract][Full Text] [Related]
10. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
[TBL] [Abstract][Full Text] [Related]
11. Disk susceptibility studies with cefazolin and cephalothin.
Actor P; Guarini J; Uri J; Dickson J; Pauls JF; Weisbach JA
Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
Shemonsky NK; Carrizosa J; Levison ME
Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
Jones RN; Fuchs PC
Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of Staphylococcus pseudintermedius susceptibility to common cephalosporins used in dogs.
Westermeyer RR; Roy AF; Mitchell MS; Merchant SR
Vet Ther; 2010; 11(3):E1-9. PubMed ID: 20960413
[TBL] [Abstract][Full Text] [Related]
16. Effect of pH upon the activity of cefoxitin.
Tobe K; Nishino T; Hirai Y; Nakazawa S
J Antibiot (Tokyo); 1977 Dec; 30(12):1123-6. PubMed ID: 23373
[No Abstract] [Full Text] [Related]
17. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
Shah PM; Zwischenbrugger H; Stille W
MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
[TBL] [Abstract][Full Text] [Related]
19. [The in vitro effect of a combination of sulbactam with cephalothin and cefazolin on strains of Escherichia coli and Proteus mirabilis which produce beta lactamase].
Múcková M; Milosovic P
Bratisl Lek Listy; 1990 Apr; 91(4):303-8. PubMed ID: 2198081
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefazolin against recent clinical bacterial isolates.
Sabath LD; Wilcox C; Garner C; Finland M
J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
